6 results
Proposed Pathophysiology of COVID19 Lung Injury

COVID19 Lung Injury model schematic based on 1) ACUTE thrombotic vascular
Proposed Pathophysiology ... of COVID19 Lung ... farid__jalali #LungInjury ... #Pathophysiology ... #COVID19 #Pulmonary
Simplified Representation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Lifecycle and Potential Drug Targets

#Therapeutic
Potential Drug Targets ... #Therapeutic #Targets ... #Pharmacology # ... SARSCOV2 #Coronavirus ... #COVID19 #JAMA
Classification of COVID-19 Disease States and Potential Therapeutic Targets

Viral Response Phase -> Host Inflammatory Response Phase
Stage
Classification of COVID ... Potential Therapeutic Targets ... Infection) Stage II (Pulmonary ... inhibitors #COVID19 ... Classification #Diagnosis #Pathophysiology
Proposed Pathophysiology of COVID19 Lung Injury

My thoughts on COVID19 Lung Injury, centered around 1) ACUTE thrombotic
Proposed Pathophysiology ... of COVID19 Lung ... farid__jalali #LungInjury ... #Pathophysiology ... #COVID19 #Pulmonary
Remdesivir (GS-5734) - manufactured by Gilead Sciences
Remdesivir blocks the replication of viruses by inserting into the
Coronavirus enters ... #Remdesivir #Pharmacology ... #Pathophysiology ... #COVID19 #SARSCOV2 ... #Coronavirus
Drugs with Actions on Bronchial Smooth Muscle
Bronchodilation is promoted by cAMP. Intracellular levels of cAMP can
#SmoothMuscle #Pathophysiology ... #Pharmacology # ... Pulmonary #Targets